December 5, 2007 5:30 PM
- Text
Cell Help After Heart Attack?
GENERIC Health : stroke heart disease: man holding his chest : heart and heart rhythmn with a caduceus (AP / CBS)
(WebMD)
Scientists say they've found a new way to help prevent a dangerous, abnormal heart rhythm after a heart attack.
Heart attack damage can cause abnormal heart rhythms , which can be life-threatening.
Researchers in Germany and the U.S. have come up with a new way to curb a risky heart rhythm called ventricular tachycardia after a heart attack.
The method -- which has been tested in mice but not in people -- involves three steps:
Among mice that had had a heart attack, ventricular tachycardia was rarer in those that received the tweaked, transplanted cells than those that didn't get such cells.
Connexin 43 was the key, report the researchers, who included Wilhelm Roell, MD, of Germany's University of Bonn.
Roell's team noticed connexin 43 in experiments that involved heart cells from mouse embryos. Genetic engineering allowed adult muscle cells to make connexin 43 without involving embryos.
The study "represents a promising therapeutic strategy to decrease the risk of potentially fatal arrhythmias," Roell and colleagues write in tomorrow's edition of Nature.
By Miranda Hitti
Reviewed by Louise Chang
©2005-2006 WebMD, Inc. All rights reserved
Heart attack damage can cause abnormal heart rhythms , which can be life-threatening.
Researchers in Germany and the U.S. have come up with a new way to curb a risky heart rhythm called ventricular tachycardia after a heart attack.
The method -- which has been tested in mice but not in people -- involves three steps:
- Taking certain muscle cells from the mice (but not from the mice's heart muscle)
- Tweaking those cells to produce a protein called connexin 43
- Injecting the tweaked muscle cells into the mice's hearts
Among mice that had had a heart attack, ventricular tachycardia was rarer in those that received the tweaked, transplanted cells than those that didn't get such cells.
Connexin 43 was the key, report the researchers, who included Wilhelm Roell, MD, of Germany's University of Bonn.
Roell's team noticed connexin 43 in experiments that involved heart cells from mouse embryos. Genetic engineering allowed adult muscle cells to make connexin 43 without involving embryos.
The study "represents a promising therapeutic strategy to decrease the risk of potentially fatal arrhythmias," Roell and colleagues write in tomorrow's edition of Nature.
By Miranda Hitti
Reviewed by Louise Chang
©2005-2006 WebMD, Inc. All rights reserved
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- 4.5 million Americans over 50 have artificial knees
- Marijuana-smoking motorists twice as likely to crash
- Skin cancer self-exam: What to look for (PHOTOS)
- Things You Didn't Know About Your Penis
- John Dye Dies: What Killed "Angel" Star?
- HealthPop: Online dating and jaw engraving
- PICTURES: 15 Shocking Sexual Fetishes
- Norovirus outbreak hits Rider University in N.J
- Online dating downsides, romantic tattoo gone wrong: HealthPop Valentine's Day video
- Woman spotlights uterus didelphys on talk show
- Christina Hendricks: Too Big for Hollywood?
- Whitney Houston back in rehab: Why?
- 8 Tips For Losing Weight After Pregnancy
- America's sodium problem: Not from salty snacks?
- Chinese mom gives birth to 15-pound baby
- Caffeine inhalers - the next club drug?
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Fuel removal under way on Italy cruise ship
- Brazil jet makes forced stop after pilot attack
- Whitney Houston's daughter taken in ambulance
- Diana Ross, Steve Jobs honored at Grammy ceremony
on Facebook Most Discussed Stories
on CBS News






